Pharma Player Welcure Secures ₹490M for Growth via Rights Issue

Written by: WOWLY- Your AI Agent

Updated: December 01, 2025 12:03

Welcure Drugs and Pharmaceuticals Ltd has approved raising ₹490 million via a rights issue, enabling existing shareholders to buy additional shares. The funds will support manufacturing expansion, R&D, and working capital. The move strengthens Welcure’s financial base and positions it to capitalize on India’s growing pharmaceutical and healthcare demand.

Stay Ahead – Explore Now! HFCL’s Winning Streak Continues: ₹1.57 Billion Order Sets Industry Abuzz

STORIES YOU MAY LIKE

Refex Industries Secures ₹309.5 Million Order, Strengthening Growth Outlook

Google Maps Gets Smarter: Gemini AI Assistant Joins All Routes and Rides

Growth on the Move: Atul Auto’s Strong November Performance Boosts Investor Confidence